0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Clinicopathologic Reports, Case Reports, and Small Case Series |

Regression of Extrafoveal Choroidal Osteoma Following Photodynamic Therapy FREE

Carol L. Shields, MD; Miguel A. Materin, MD; Sonul Mehta, MD; Brett T. Foxman, MD; Jerry A. Shields, MD
[+] Author Affiliations

Section Editor: W. Richard Green, MD

More Author Information
Arch Ophthalmol. 2008;126(1):135-137. doi:10.1001/archopht.126.1.135.
Text Size: A A A
Published online

Choroidal osteoma is a rare intraocular tumor, composed of mature calcified bone and typically found in young adult women.1,2 Long-term findings of this benign tumor include tumor growth in 51%, tumor decalcification in 46%, development of choroidal neovascularization in 31%, and visual acuity of 20/200 or worse in 56%.3 Tumor decalcification usually occurs spontaneously after many years.3 Laser photocoagulation for choroidal neovascularization can induce focal tumor decalcification.4 Decalcification is important because this minimizes further growth of the tumor at that site and could protect the fovea from tumor involvement and visual loss.3 We report photodynamic therapy to an extrafoveal choroidal osteoma that induced decalcification and resorption of bone, leaving a small area of subretinal fibrosis.

REPORT OF A CASE

An asymptomatic 25-year-old woman had a juxtapapillary choroidal osteoma in her right eye, measuring 3 mm in diameter. Her visual acuity was 20/20 in each eye. An overlying subretinal hemorrhage was present (Figure 1). Ultrasonography showed an echodense mass consistent with calcium. Observation was advised.

Place holder to copy figure label and caption
Figure 1.

Findings before photodynamic therapy: a small juxtapapillary choroidal osteoma with overlying subretinal hemorrhage (A), ultrasonography confirmed the calcified choroidal tumor with acoustic shadowing (B), and optical coherence tomography showed slight elevation of the mass (between arrows) with minimal light shadowing and an intact photoreceptor layer (C).

Graphic Jump Location

On follow-up at 6 and 18 months, the stable mass showed persistent hemorrhage, suggesting choroidal neovascularization. Photodynamic therapy to the entire osteoma was performed using a single 83-second laser spot at 689 nm (50 J/cm2) coupled with intravenous verteporfin, 6 mg/m2. The hemorrhage resolved by 1 month. The bone remained intact until 9 months, when there was complete disappearance of the osteoma, leaving a 2-mm region of subretinal fibrosis and retinal pigment epithelial hyperplasia (Figure 2).

Place holder to copy figure label and caption
Figure 2.

Findings 9 months after single photodynamic therapy: the hemorrhage and mass were completely resolved, leaving only subretinal fibrosis and retinal pigment epithelial hyperplasia (A); ultrasonography showed no evidence of calcium (B); and optical coherence tomography showed the subretinal tissue with shadowing from retinal pigment epithelial hyperplasia and transmission through fibrosis (between arrows) (C).

Graphic Jump Location

COMMENT

The reasons for vision loss from choroidal osteoma include photoreceptor degeneration, subfoveal fluid, and subfoveal hemorrhage from related choroidal neovascularization. In an analysis of 74 eyes with choroidal osteoma, good visual acuity (20/20-20/40) was found in 24 of 30 eyes (80%) without foveolar involvement of tumor compared with 20 of 44 eyes (45%) with foveolar involvement.3 In addition, tumors with decalcification showed little or no growth in the direction of the decalcification.3 Based on these observations, inhibition of tumor growth into the foveola by stimulating decalcification within the entire tumor or at least the portion of the tumor nearest the foveola could protect long-term visual acuity.

Decalcification of choroidal osteoma appears as an atrophic flat bed of retinal pigment epithelium and choroid. Decalcification typically occurs spontaneously and initiates in the central part (37%), peripheral part (48%), or diffusely (15%) within the osteoma.3 Progressive decalcification occurs slowly and occupies approximately 40% of the tumor by 10 years.3 Laser photocoagulation can induce focal tumor decalcification.2,3 In this report, we observed that photodynamic therapy caused decalcification and involution of the entire tumor. This finding is important because photodynamic therapy could be a therapeutic modality for choroidal neovascularization and induction of decalcification of extrafoveal osteoma to prevent tumor growth into the foveola.

These results should not be extrapolated to subfoveal choroidal osteoma.3 It is speculated that decalcification of subfoveal choroidal osteoma could result in worse visual acuity because of loss of retinal pigment epithelium and choroidal perfusion.

ARTICLE INFORMATION

Correspondence: Dr C. L. Shields, Ocular Oncology Service, Wills Eye Hospital, 840 Walnut St, Ste 1440, Philadelphia, PA 19107 (carol.shields@shieldsoncology.com).

Author Contributions: Dr C. L. Shields had full access to all the data in the study and takes responsibility for the integrity and accuracy of the data analysis.

Financial Disclosure: None reported.

Funding/Support: This study was supported by the Retina Research Foundation of the Retina Society, Cape Town,South Africa (Dr C. L. Shields); Mellon Charitable Giving from the Martha W. Rogers Charitable Trust, Philadelphia, Pennsylvania (Dr C. L. Shields); the LuEsther Mertz Retina Research Foundation, New York, New York (Dr C. L. Shields); a donation from Michael, Bruce,and Ellen Ratner, New York (Drs C. L. Shields and J. A. Shields); the Eye Tumor Research Foundation, Philadelphia (Drs C. L. Shields and J. A. Shields); and the Paul Kayser International Award of Merit in Retina Research, Houston, Texas (Dr J. A. Shields).

REFERENCES

Gass  JDGuerry  RKJack  RLHarris  G Choroidal osteoma. Arch Ophthalmol 1978;96 (3) 428- 435
PubMed Link to Article
Shields  CLShields  JAAugsburger  JJ Review of choroidal osteomas. Surv Ophthalmol 1988;33 (1) 17- 27
PubMed Link to Article
Shields  CLSun  HDemirci  HShields  JA Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma. Arch Ophthalmol 2005;123 (12) 1658- 1666
PubMed Link to Article
Trimble  SNSchatz  H Decalcification of a choroidal osteoma. Br J Ophthalmol 1991;75 (1) 61- 63
PubMed Link to Article

Figures

Place holder to copy figure label and caption
Figure 1.

Findings before photodynamic therapy: a small juxtapapillary choroidal osteoma with overlying subretinal hemorrhage (A), ultrasonography confirmed the calcified choroidal tumor with acoustic shadowing (B), and optical coherence tomography showed slight elevation of the mass (between arrows) with minimal light shadowing and an intact photoreceptor layer (C).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Findings 9 months after single photodynamic therapy: the hemorrhage and mass were completely resolved, leaving only subretinal fibrosis and retinal pigment epithelial hyperplasia (A); ultrasonography showed no evidence of calcium (B); and optical coherence tomography showed the subretinal tissue with shadowing from retinal pigment epithelial hyperplasia and transmission through fibrosis (between arrows) (C).

Graphic Jump Location

Tables

References

Gass  JDGuerry  RKJack  RLHarris  G Choroidal osteoma. Arch Ophthalmol 1978;96 (3) 428- 435
PubMed Link to Article
Shields  CLShields  JAAugsburger  JJ Review of choroidal osteomas. Surv Ophthalmol 1988;33 (1) 17- 27
PubMed Link to Article
Shields  CLSun  HDemirci  HShields  JA Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma. Arch Ophthalmol 2005;123 (12) 1658- 1666
PubMed Link to Article
Trimble  SNSchatz  H Decalcification of a choroidal osteoma. Br J Ophthalmol 1991;75 (1) 61- 63
PubMed Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

986 Views
6 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs